• Press
  • Offices
  • Contact
  • Legal notice
  • EN
    • DE
  • UPC
  • Firm
    • Main Focus
    • History
    • Guiding Principle
    • Awards and Rankings
  • Our Practice
    • Legal Areas
    • Industries
  • Our Team
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • Brexit-Update
    • Publications
    • B&B Bulletin
  • Career
    • Working with us
  • Menu Menu
FIND EXPERTS
  • UPC
  • Firm
    • Main Focus
    • History
    • Guiding Principle
    • Awards and Rankings
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • Brexit-Update
    • Publications
    • B&B Bulletin
  • FIND EXPERTS
  • Contact
  • Our Practice
    • Legal Areas
    • Industries
  • Our Team
  • Career
    • Working with us
  • Offices
  • EN
    • DE

“BioNTech goes – what does Germany do?” article by Dr. Ute Kilger and Elmar Jehn in the maga­zine “Euro­pean Bio­tech­nolo­gy”

22. March 2023/in Publications

BioNTech, the superstar of mRNA research, announces its strategic partnership with the British government at the beginning of January 2023 and with it the establishment of a regional headquarters for the company in London for the development and application of personalised mRNA therapies and vaccines against cancer.

A step that raises questions about Germany as a research location. The framework conditions for such projects seem to be more attractive elsewhere – shouldn’t this be a wake-up call for the German biotech industry?

In their article “BioNTech goeas – what does Germany do?” in the spring issue of the trade magazine “European Biotechnology”, BOEHMERT & BOEHMERT partner and patent attorney Dr. Ute Kilger and Elmar Jehn, partner at Global Nation Consulting, analyse the German response to the BioN-Tech decision and attest to the fact that politics and industry representatives are generally too defensive in international competition.
While politicians have to make the framework conditions more efficient and research-friendly, the biotech industry itself has to represent its interests more clearly. What is needed is greater self-confidence in view of the immense contribution of research-based companies to the well-being of people and the economy. What is needed is a political and media offensive that focuses on the achievements of biotech and at the same time conveys understanding and knowledge for the requirements of a successful research future.
BioNTech’s decision shows that others in the industry must exert all the more influence on German politics to push forward legislative projects for faster procedures for the approval of factories, medicines and research projects.

The article of Dr. Ute Kilger and Elmar Jehn is available in English here on page 12 of the e-Journal of European Biotechnology.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Lucia Biehl /wp-content/uploads/2022/04/boehmert_logo.svg Lucia Biehl2023-03-22 12:32:342023-03-23 11:07:37“BioNTech goes – what does Germany do?” article by Dr. Ute Kilger and Elmar Jehn in the maga­zine “Euro­pean Bio­tech­nolo­gy”

Author

Dr. Ute Kilger

Contents

More articles

  • Dr. Rudolf Böckenholt comments on the ruling of the Berlin… 25. May 2023
  • Fabio Adinolfi comments on ECJ judg­ment T-423/21 on the… 4. May 2023
  • "Digital patents are worth their weight in gold" - article… 6. April 2023

Menu

  • Firm
  • Our Practice
  • Career
  • News & Knowledge
  • FIND EXPERTS

Informations

  • Press
  • Contact
  • Legal notice
  • Data Protection
  • General Terms and Conditions
  • Contact

Legal Areas

  • Employee Inventions
  • Data Protection
  • Designs
  • Domains
  • Information Technology
  • Anti-Trust
  • Licensing
  • Trade Marks
  • Patent Valuation
  • Patents & Utility Models
  • Patent Litigation
  • Product Piracy
  • Copyright
  • Unfair Competition

© Copyright 2023– BOEHMERT & BOEHMERT

Scroll to top

We only use functional cookies and no third party services. Learn more in our privacy policy.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.